BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1461605)

  • 1. Membranous nephropathy: a 19 year prospective study in 51 patients.
    Hay NM; Bailey RR; Lynn KL; Robson RA
    N Z Med J; 1992 Dec; 105(947):489-91. PubMed ID: 1461605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of untreated patients with idiopathic membranous nephropathy.
    Schieppati A; Mosconi L; Perna A; Mecca G; Bertani T; Garattini S; Remuzzi G
    N Engl J Med; 1993 Jul; 329(2):85-9. PubMed ID: 8510707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
    Passerini P; Pasquali S; Cesana B; Zucchelli P; Ponticelli C
    Nephrol Dial Transplant; 1989; 4(6):525-9. PubMed ID: 2507973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
    Polanco N; Gutiérrez E; Rivera F; Castellanos I; Baltar J; Lorenzo D; Praga M;
    Nephrol Dial Transplant; 2012 Jan; 27(1):231-4. PubMed ID: 21624942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
    Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of patients with idiopathic membranous nephropathy.
    Ríhová Z; Merta M; Maixnerová D; Honsová E; Reiterová J; Rysavá R; Zabka J; Tesar V
    Prague Med Rep; 2006; 107(2):189-98. PubMed ID: 17066739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Membranous glomerulonephritis].
    Polenaković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():18-25. PubMed ID: 9102898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical course in 51 patients with idiopathic membranous glomerulopathy].
    Ardiles L; Mezzano S; Arriagada A; Caorsi I
    Rev Med Chil; 1989 Mar; 117(3):266-72. PubMed ID: 2488518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
    J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
    Shearman JD; Yin ZG; Aarons I; Smith PS; Woodroffe AJ; Clarkson AR
    Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.
    Laluck BJ; Cattran DC
    Am J Kidney Dis; 1999 Jun; 33(6):1026-32. PubMed ID: 10352189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remissions and relapses in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Altieri P; Locatelli F; Pappalettera M
    Nephrol Dial Transplant; 1992; 7 Suppl 1():85-90. PubMed ID: 1337188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.